Processes for the preparation of lesinurad and intermediates thereof

US10351537B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10351537-B2
Application numberUS-201815914165-A
CountryUS
Kind codeB2
Filing dateMar 7, 2018
Priority dateMar 10, 2017
Publication dateJul 16, 2019
Grant dateJul 16, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provides processes for the preparation of Lesinurad (1), as well as intermediates useful in the preparation thereof. In particular, the processes of the invention utilize novel intermediate compounds of Formulas (3) and (11), which provide improvements over the known processes for the preparation of Lesinurad (1).

First claim

Opening claim text (preview).

What is claimed is: 1. A process for the preparation of Lesinurad (1): or a salt thereof, the process comprising hydrolysis, in the presence of a solvent (S3), of a compound of Formula (2): wherein L is a linker corresponding with the backbone of either: (a) a monomeric polyol having x hydroxyl substituents, each bonded to a different carbon atom; (b) a water-soluble polymeric polyol having x mean hydroxyl substituents, each bonded to a different carbon atom; or (c) a water-insoluble polymeric polyol suitable for use as a solid phase support having x mean hydroxyl substituents, each bonded to a different carbon atom; and wherein the hydroxyl substituents of the polyol provide the oxygen atoms in the ester connection in the compound of Formula (2); x and z1 are each at least 2; and z1≤x. 2. The process of claim 1 , wherein L is a linker corresponding with the backbone of a monomeric polyol selected from the group consisting of C2-C10 aliphatic diols, C3-C10 aliphatic triols, C4-C20 aliphatic tetrols, saccharides and sugar alcohols. 3. The process of claim 2 , wherein the monomeric polyol is ethane-1,2-diol or propane-1,2,3-triol. 4. The process of claim 3 , wherein the monomeric polyol is ethane-1,2-diol and x and z1 are both 2. 5. The process of claim 1 , wherein the hydrolysis is conducted in the presence of a base (B2). 6. The process of claim 5 , wherein the base (B2) is an alkali metal hydroxide. 7. The process of claim 6 , wherein the base (B2) is lithium hydroxide. 8. The process of claim 1 , wherein the solvent (S3) is selected from the group consisting of water and ethers. 9. The process of claim 3 , wherein the compound of Formula (2) is prepared by a process comprising reacting, in the presence of a solvent (S2), a compound of Formula (3): with a brominating agent, wherein L is a linker corresponding with the backbone of a monomeric polyol selected from the group consisting of ethane-1,2-diol and propane-1,2,3-triol; and z is 2 or 3. 10. The process of claim 9 , wherein the brominating agent is selected from the group consisting of 1,3-dibromo-5,5-dimethylhydantoin and N-bromosuccinimide. 11. The process of claim 10 , wherein the brominating agent is 1,3-dibromo-5,5-dimethylhydantoin. 12. The process of claim 9 , wherein the solvent (S2) is selected from the group consisting of acetonitrile, N,N-dimethylformamide, ethyl acetate, isopropyl acetate, methyl t-butyl ether, tetrahydrofuran, dioxane, dichloromethane, methanol, cyclohexane and hexane. 13. The process of claim 9 , wherein the compound of Formula (2) is not isolated. 14. The process of claim 9 , wherein the compound of Formula (3) is prepared by a process comprising reaction of a compound of Formula (5): in the presence of a base (B1) and a solvent (S1), with a compound of Formula (4): wherein L is a linker corresponding with the backbone of a monomeric polyol selected from the group consisting of ethane-1,2-diol and propane-1,2,3-triol; G 1 is a leaving group; and y is 2 or 3. 15. The process of claim 14 , wherein G 1 is a halide. 16. The process of claim 14 , wherein the solvent (S1) is N,N-dimethylformamide. 17. A compound of Formula (3): wherein L is a linker corresponding with the backbone of a monomeric polyol selected from the group consisting of ethane-1,2-diol and propane-1,2,3-triol; wherein the hydroxyl substituents of the polyol provide the oxygen atoms in the ester connection in the compound of Formula (3); and z is 2 or 3. 18. A compound of Formula (2): wherein L is a linker corresponding with the backbone of either: (a) a monomeric polyol having x hydroxyl substituents, each bonded to a different carbon atom; (b) a water-soluble polymeric polyol having x mean hydroxyl substituents, each bonded to a different carbon atom; or (c) a water-insoluble polymeric polyol suitable for use as a solid phase support having x mean hydroxyl substituents, each bonded to a different carbon atom; and wherein the hydroxyl substituents of the polyol provide the oxygen atoms in the ester connection in the compound of Formula (2); x and z1 are each at least 2; and z1≤x. 19. The compound of claim 18 , wherein L is a linker corresponding with the backbone of a monomeric polyol selected from the group consisting of C2-C10 aliphatic diols, C3-C10 aliphatic triols, C4-C20 aliphatic tetrols, saccharides and sugar alcohols. 20. The compound of claim 19 , selected from:

Assignees

Inventors

Classifications

  • C07D249/12Primary

    Oxygen or sulfur atoms · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10351537B2 cover?
The present invention provides processes for the preparation of Lesinurad (1), as well as intermediates useful in the preparation thereof. In particular, the processes of the invention utilize novel intermediate compounds of Formulas (3) and (11), which provide improvements over the known processes for the preparation of Lesinurad (1).
Who is the assignee on this patent?
Apotex Inc
What technology area does this patent fall under?
Primary CPC classification C07D249/12. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jul 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).